Molecular characterization of Turkish patients with pyrimidine 5' nucleotidase-I deficiency

Blood. 2003 Sep 1;102(5):1900-3. doi: 10.1182/blood-2003-02-0628. Epub 2003 Apr 24.

Abstract

Pyrimidine 5' nucleotidase-I (P5N-I) deficiency is a rare autosomal recessive disorder associated with hemolytic anemia, marked basophilic stippling, and accumulation of high concentrations of pyrimidine nucleotides within the erythrocyte. Recently, the structure and location of the P5N-I gene have been published. This paper presents the results of a study characterizing the molecular pathologies of P5N-I deficiency in a total of 6 Turkish patients from 4 unrelated families of consanguineous marriages. Mutation analysis in the P5N-I gene led to the identification of 3 novel mutations in these patients. In 4 patients from 2 families, a homozygous insertion of double G at position 743 was detected in exon 9 (743-744insGG), leading to premature termination of translation 23 bp downstream. In one family, a homozygous T to G transition at position 543 (543T>G) in exon 8 resulted in the replacement of tyrosine (Tyr) with a stop codon (Tyr181Stop). In another family, a homozygous insertion of a single A in exon 7 (384-385insA) created a stop signal at the codon nearby. In all families, the parents were heterozygous for the relevant mutations. None of these changes was detected in 200 chromosomes from a healthy Turkish population. These mutations were not correlated with any particular phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5'-Nucleotidase / genetics*
  • Adolescent
  • Adult
  • Anemia, Hemolytic, Congenital / enzymology*
  • Anemia, Hemolytic, Congenital / genetics*
  • Child
  • Consanguinity
  • DNA Mutational Analysis
  • Family Health
  • Female
  • Genes, Recessive
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • Point Mutation*
  • TATA Box / genetics
  • Turkey

Substances

  • 5'-Nucleotidase